Frozen Tumor Tissues Samples Segment to Lead Frozen Tissues Samples Market During 2021–2028
According to our latest study, "Frozen Tissues Samples Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product Type, Application, and End User," the market is expected to grow from US$ 44,399.07 thousand in 2021 to US$ 105,045.91 thousand by 2028; it is estimated to grow at a CAGR of 13.1% from 2021 to 2028. The report highlights the key factors driving the market and prominent players with their developments. The growth of the frozen tissues samples market is primarily attributed to the rising application of frozen tissue samples in various research & therapeutic areas and the increasing use of frozen tissue samples due to the rising prevalence of cancer. However, the risk associated with preserving and maintaining frozen tissue samples is hampering the market's growth to a certain extent.
The companies engaging in the frozen tissues samples market witnessed a negative impact on their services in early 2020 due to the temporary shutdown of their laboratories caused by the COVID-19 pandemic. Most service providers prioritized actions to help the critical work of consumers included in COVID-19, such as giving a range of high-quality COVID-19 related research tools, reassigning R&D resources for producing essential products for SARS-Cov-2, expanding the supply chain, providing flexibility to support expanded demand for enduring products applied for SARS-CoV-2/COVID-19 research, and entering into discussions and collaborations across the UK, the US, and China concentrated on SARS-CoV-2 diagnostics, drugs, and vaccines development. The cancer-based research activities using frozen tissue samples during the pandemic were restricted due to the temporary shutdown of the laboratories. However, as lockdown limitations were gradually lifted, research laboratories worldwide started reopening.
Based on product type, the frozen tissues samples market is segmented into frozen normal tissue samples, frozen tumor tissue samples, and frozen diseased tissue samples. In 2021, the frozen tumor tissue samples segment held the largest market share and is estimated to grow at the fastest CAGR of 13.4% during the forecast period. The largest share of this segment is due to the technological developments and rise in product approvals for the frozen tissues samples. For instance, in 2020, IceCure Medical announced that the Central Drugs Standard Control Organisation (CDSCO)—Indian regulatory authority had granted a license for the sale and marketing of IceCure's ProSense system and associated products for the destruction of tissue by cryoablation in extensive indications, including breast, lung, bone, and kidney cancer. Frozen tissue samples are majorly designed to diagnose and treat various types of cancers. At the same time, new candidates are also being explored for other indications such as infectious diseases and central nervous system disorders. For instance, BioChain offers ready-to-use, next-generation sequencing (NGS) characterized tissue samples for BReast CAncer gene 1(BRCA1), BReast CAncer gene 2 (BRCA2), Microsatellite Instability (MSI), HPV, Epidermal Growth Factor Receptor (EGFR), and Kirsten rat sarcoma virus (KRAS), developing the new mutation-specific bio-samples in response to the growing need and demand from researchers for oncology researchers studying pathways related to BRCA1 and BRCA2. The factors mentioned above are expected to propel the growth of the frozen tissues samples market.
Audubon Bioscience Co; REPROCELL Inc.; Bay Biosciences LLC; US Biolab Corporation, Inc; AMS Biotechnology (Europe) Ltd.; Geneticist, Inc.; ZenBio, Inc.; OriGene Technologies, Inc.; BioChain Institute Inc.; and ProteoGenex, Inc. are a few leading companies operating in the frozen tissues samples market.
Report : Frozen Tissues Samples Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Frozen Normal Tissue Samples, Frozen Tumor Tissue Samples, and Frozen Diseased Tissue Samples), Application (Disease Diagnosis & Treatment, Cancer & Other Diseases Research, and Morphological Analysis), and End User (Academic & Research Institutes, Hospitals & Clinics, Diagnostic Centers, and Others)
Based on product type, the frozen tissues samples market is segmented into frozen normal tissue samples, frozen tumor tissue samples, and frozen diseased tissue samples. Based on application, the market is segmented into disease diagnosis & treatment, cancer & other diseases research, and morphological analysis. Based on end user, the market is segmented into academic & research institutes, hospitals & clinics, diagnostic centers, and others. By geography, the frozen tissues samples market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Contact Person: Sameer Joshi
Email Id: firstname.lastname@example.org